AG
EDSA icon

Advisor Group’s Edesa Biotech EDSA Stock Holding History

Advisor Group’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Sell
18
-6
-25% -$212 ﹤0.01% 5126
2019
Q3 		$1K Buy
24
+15
+167% +$544 ﹤0.01% 5102
2019
Q2 		$0 Sell
9
-12
-57% -$528 ﹤0.01% 5258
2019
Q1 		$1K Sell
21
-6
-22% -$296 ﹤0.01% 5054
2018
Q4 		$1K Hold
27
– – ﹤0.01% 4952
2018
Q3 		$2K Hold
27
– – ﹤0.01% 4842
2018
Q2 		$2K Sell
27
-3
-10% -$429 ﹤0.01% 4660
2018
Q1 		$7K Buy
30
+26
+650% +$6.43K ﹤0.01% 4262
2017
Q4 		$1K Sell
4
-74
-95% -$23.6K ﹤0.01% 4808
2017
Q3 		$26K Hold
78
– – ﹤0.01% 3404
2017
Q2 		$28K Sell
78
-12
-13% -$4.53K ﹤0.01% 3256
2017
Q1 		$43K Buy
90
+2
+2% +$1.06K ﹤0.01% 2825
2016
Q4 		$53K Sell
88
-45
-34% -$27.7K ﹤0.01% 2574
2016
Q3 		$94K Sell
133
-6
-4% -$5.03K ﹤0.01% 2046
2016
Q2 		$155K Buy
+139
New +$143K ﹤0.01% 1629

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Advisor Group's EDSA Position: Q4 2019 in Review

Advisor Group reduced its Edesa Biotech (EDSA) stake by 25% in Q4 2019, selling an estimated $212 and leaving 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5126.

Advisor Group first reported a position in EDSA in Q2 2016 and has held it in 15 quarters since. The position peaked at $155K in Q2 2016. 9 funds tracked by Wall St. Rank hold EDSA as of Q4 2019.

  • Advisor Group held 18 shares of Edesa Biotech worth $1K as of Q4 2019.
  • Advisor Group sold 6 Edesa Biotech shares in Q4 2019, an estimated $212.
  • Edesa Biotech made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5126 holding.
  • Advisor Group first reported a position in Edesa Biotech in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Edesa Biotech position peaked at $155K in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.